Enfusion, which provides cloud-based investment management software, raised $319 million by offering 18.8 million shares at $17, the high end of the range of $15 to $17.
Enfusion plans to list on the NYSE under the symbol ENFN. Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse, Piper Sandler, Stifel, and William Blair acted as joint bookrunners on the deal.
